PCM
JNCE

Pathway Capital Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Pathway Capital Management’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-84,763
Closed -$630K – 20
2021
Q3 		$630K Buy
84,763
+24,484
+41% +$182K 0.3% 18
2021
Q2 		$410K Buy
+60,279
New +$410K 0.16% 21